Evidence map›Paper›PMID 28628644›Full record

ArticlePloS one2017

Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells.

Mariela Rivera, Yanilda Ramos, Madeline Rodríguez-Valentín, Sheila López-Acevedo, Luis A Cubano, Jin Zou, Qiang Zhang, Guangdi Wang, Nawal M Boukli

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Toxicology reports · 2026
    Article
  3. Article
  4. Review
  5. Dual RNase activity of IRE1 as a target for anticancer therapies.Journal of cell communication and signaling · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Molecular Targets of Natural Compounds with Anti-Cancer Properties.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mariela RiveraDepartment of Microbiology and Immunology, Biomedical Proteomics Facility, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, United States of America.
Yanilda RamosDepartment of Microbiology and Immunology, Biomedical Proteomics Facility, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, United States of America.
Madeline Rodríguez-ValentínDepartment of Microbiology and Immunology, Biomedical Proteomics Facility, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, United States of America.
Sheila López-AcevedoDepartment of Microbiology and Immunology, Biomedical Proteomics Facility, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, United States of America.
Luis A CubanoDepartment of Microbiology and Immunology, Biomedical Proteomics Facility, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, United States of America.
Jin ZouCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia, United States of America.
Qiang ZhangDepartment of Chemistry, RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, Louisiana, United States of America.
Guangdi WangDepartment of Chemistry, RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, Louisiana, United States of America.
Nawal M BoukliDepartment of Microbiology and Immunology, Biomedical Proteomics Facility, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, United States of America.ORCID http://orcid.org/0000-0003-0919-9936
Central University of the Caribbean · PRXavier University of Louisiana · USCenter for Cancer Research · US

Funding

Xavier's RCMI Cancer Research ProgramG12MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI D'AMOUR, GENE, WANG, GUANGDI · 2012 to 2018
$15.7M
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERSG12MD007583 · NIMHD · UNIVERSIDAD CENTRAL DEL CARIBE · PI FERNANDEZ, DIANA MARIA · 2012 to 2016
$8.4M
Technologies/Resources for Core LaboratoriesG12MD007590 · NIMHD · CLARK ATLANTA UNIVERSITY · PI KHAN, SHAFIQ A · 2012 to 2018
$7.6M
NIMHD NIH HHS G12 MD007583NIMHD NIH HHS G12 MD007590NIMHD NIH HHS G12 MD007595
6 · The paper itself

Abstract

Curcumin, an extract from the turmeric rhizome (Curcuma longa), is known to exhibit anti-inflammatory, antioxidant, chemopreventive and antitumoral activities against aggressive and recurrent cancers. Accumulative data indicate that curcumin may induce cancer cell death. However, the detailed mechanism underlying its pro-apoptotic and anti-cancer effects remains to be elucidated. In the present study, we examined the signaling pathways triggered by curcumin, specifically, the exact molecular mechanisms of curcumin-induced apoptosis in highly metastatic human prostate cancer cells. The effect of curcumin was evaluated using for the first time in prostate cancer, a gel-free shotgun quantitative proteomic analysis coupled with Tandem Mass Tag isobaric labeling-based-signaling networks. Results were confirmed at the gene expression level by qRT-PCR and at the protein expression level by western blot and flow cytometry. Our findings revealed that curcumin induced an Endoplasmic Reticulum stress-mediated apoptosis in PC3. The mechanisms by which curcumin promoted cell death in these cells were associated with cell cycle arrest, increased reactive oxygen species, autophagy and the Unfolded Protein Response. Furthermore, the upregulation of ER stress was measured using key indicators of ER stress: Glucose-Regulated Protein 78, Inositol-Requiring Enzyme 1 alpha, Protein Disulfide isomerase and Calreticulin. Chronic ER stress induction was concomitant with the upregulation of pro-apoptotic markers (caspases 3,9,12) and Poly (ADP-ribose) polymerase. The downregulated proteins include anti-apoptotic and anti-tumor markers, supporting their curcumin-induced pro-apoptotic role in prostate cancer cells. Taken together, these data suggest that curcumin may serve as a promising anticancer agent by inducing a chronic ER stress mediated cell death and activation of cell cycle arrest, UPR, autophagy and oxidative stress responses.

Indexed as

AnimalsAntineoplastic AgentsApoptosisApoptosis Regulatory ProteinsCalreticulinCaspase 3Cell Cycle CheckpointsCell Line, TumorChromatography, High Pressure LiquidCurcuminDown-RegulationEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressHeat-Shock ProteinsMaleProstatic NeoplasmsAntineoplastic AgentsApoptosis Regulatory ProteinsCalreticulinCaspase 3CurcuminEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsProtein Disulfide-Isomerases

Identifiers

PMID28628644
PMCPMC5476315
OpenAlexW2638864431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.